Alka Chaubey is Chief Medical Officer of Bionano Genomics, Inc.. Currently has a direct ownership of 45,323 shares of BNGO, which is worth approximately $11,330. The most recent transaction as insider was on Sep 11, 2024, when has been sold 3,075 shares (Common Stock) at a price of $0.48 per share, resulting in proceeds of $1,476. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.3K
6.06% 3M change
68.7% 12M change
Total Value Held $11,330

Alka Chaubey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 11 2024
SELL
Payment of exercise price or tax liability
$1,476 $0.48 p/Share
3,075 Reduced 6.35%
45,323 Common Stock
Jun 03 2024
BUY
Grant, award, or other acquisition
-
16,000 Added 24.9%
48,245 Common Stock
Feb 15 2024
SELL
Payment of exercise price or tax liability
$1,372 $1.27 p/Share
1,081 Reduced 3.32%
31,487 Common Stock
Sep 18 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 12.14%
144,794 Common Stock
Feb 15 2023
BUY
Grant, award, or other acquisition
-
120,000 Added 49.02%
124,794 Common Stock
AC

Alka Chaubey

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on BNGO

Follow Bionano Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BNGO shares.

Notify only if

Insider Trading

Get notified when an Bionano Genomics, Inc. insider buys or sells BNGO shares.

Notify only if

News

Receive news related to Bionano Genomics, Inc.

Track Activities on BNGO